The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Preparation Market Research Report 2025
Synopsis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
The global Insulin Preparation market was valued at US$ 25780 million in 2023 and is anticipated to reach US$ 36510 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Insulin Preparation market is driven by the escalating global prevalence of diabetes and the growing need for effective diabetes management solutions. Insulin, a critical hormone for regulating blood sugar levels, plays a pivotal role in treating both type 1 and type 2 diabetes. The rise in diabetes cases, particularly due to sedentary lifestyles and unhealthy dietary habits, contributes to market growth as patients and healthcare providers seek reliable and accessible insulin preparations. Moreover, advancements in insulin delivery methods, such as pens, pumps, and inhalers, align with improved treatment convenience and adherence. However, the market also faces challenges, including the complexity of insulin dosing and administration, and the need for continuous patient education. Additionally, ensuring affordability and accessibility of insulin products, particularly in low-resource settings, and addressing potential adverse effects can pose obstacles for manufacturers. To succeed, companies must focus on patient-centric solutions, technological innovations in insulin delivery, and addressing the challenges to meet the increasing demand for safe and effective insulin preparations that enhance the quality of life for individuals living with diabetes.
This report aims to provide a comprehensive presentation of the global market for Insulin Preparation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Preparation.
Report Scope
The Insulin Preparation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Preparation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Preparation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Segment by Type
Fast-acting
Intermediate-acting
Long-acting
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes. In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin.
The global Insulin Preparation market was valued at US$ 25780 million in 2023 and is anticipated to reach US$ 36510 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The Insulin Preparation market is driven by the escalating global prevalence of diabetes and the growing need for effective diabetes management solutions. Insulin, a critical hormone for regulating blood sugar levels, plays a pivotal role in treating both type 1 and type 2 diabetes. The rise in diabetes cases, particularly due to sedentary lifestyles and unhealthy dietary habits, contributes to market growth as patients and healthcare providers seek reliable and accessible insulin preparations. Moreover, advancements in insulin delivery methods, such as pens, pumps, and inhalers, align with improved treatment convenience and adherence. However, the market also faces challenges, including the complexity of insulin dosing and administration, and the need for continuous patient education. Additionally, ensuring affordability and accessibility of insulin products, particularly in low-resource settings, and addressing potential adverse effects can pose obstacles for manufacturers. To succeed, companies must focus on patient-centric solutions, technological innovations in insulin delivery, and addressing the challenges to meet the increasing demand for safe and effective insulin preparations that enhance the quality of life for individuals living with diabetes.
This report aims to provide a comprehensive presentation of the global market for Insulin Preparation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Preparation.
Report Scope
The Insulin Preparation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Preparation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Preparation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Segment by Type
Fast-acting
Intermediate-acting
Long-acting
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Preparation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Preparation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insulin Preparation Market Overview
1.1 Product Overview and Scope of Insulin Preparation
1.2 Insulin Preparation Segment by Type
1.2.1 Global Insulin Preparation Market Value Comparison by Type (2024-2030)
1.2.2 Fast-acting
1.2.3 Intermediate-acting
1.2.4 Long-acting
1.3 Insulin Preparation Segment by Application
1.3.1 Global Insulin Preparation Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Insulin Preparation Market Size Estimates and Forecasts
1.4.1 Global Insulin Preparation Revenue 2019-2030
1.4.2 Global Insulin Preparation Sales 2019-2030
1.4.3 Global Insulin Preparation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Preparation Market Competition by Manufacturers
2.1 Global Insulin Preparation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Preparation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Preparation Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Preparation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Preparation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Preparation, Product Type & Application
2.7 Insulin Preparation Market Competitive Situation and Trends
2.7.1 Insulin Preparation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Preparation Players Market Share by Revenue
2.7.3 Global Insulin Preparation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Preparation Retrospective Market Scenario by Region
3.1 Global Insulin Preparation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Preparation Global Insulin Preparation Sales by Region: 2019-2030
3.2.1 Global Insulin Preparation Sales by Region: 2019-2024
3.2.2 Global Insulin Preparation Sales by Region: 2025-2030
3.3 Global Insulin Preparation Global Insulin Preparation Revenue by Region: 2019-2030
3.3.1 Global Insulin Preparation Revenue by Region: 2019-2024
3.3.2 Global Insulin Preparation Revenue by Region: 2025-2030
3.4 North America Insulin Preparation Market Facts & Figures by Country
3.4.1 North America Insulin Preparation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Preparation Sales by Country (2019-2030)
3.4.3 North America Insulin Preparation Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Preparation Market Facts & Figures by Country
3.5.1 Europe Insulin Preparation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Preparation Sales by Country (2019-2030)
3.5.3 Europe Insulin Preparation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Preparation Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Preparation Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Preparation Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Preparation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Preparation Market Facts & Figures by Country
3.7.1 Latin America Insulin Preparation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Preparation Sales by Country (2019-2030)
3.7.3 Latin America Insulin Preparation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Preparation Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Preparation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Preparation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Preparation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Preparation Sales by Type (2019-2030)
4.1.1 Global Insulin Preparation Sales by Type (2019-2024)
4.1.2 Global Insulin Preparation Sales by Type (2025-2030)
4.1.3 Global Insulin Preparation Sales Market Share by Type (2019-2030)
4.2 Global Insulin Preparation Revenue by Type (2019-2030)
4.2.1 Global Insulin Preparation Revenue by Type (2019-2024)
4.2.2 Global Insulin Preparation Revenue by Type (2025-2030)
4.2.3 Global Insulin Preparation Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Preparation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Preparation Sales by Application (2019-2030)
5.1.1 Global Insulin Preparation Sales by Application (2019-2024)
5.1.2 Global Insulin Preparation Sales by Application (2025-2030)
5.1.3 Global Insulin Preparation Sales Market Share by Application (2019-2030)
5.2 Global Insulin Preparation Revenue by Application (2019-2030)
5.2.1 Global Insulin Preparation Revenue by Application (2019-2024)
5.2.2 Global Insulin Preparation Revenue by Application (2025-2030)
5.2.3 Global Insulin Preparation Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Preparation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Insulin Preparation Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi-Aventis
6.2.1 Sanofi-Aventis Corporation Information
6.2.2 Sanofi-Aventis Description and Business Overview
6.2.3 Sanofi-Aventis Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Aventis Insulin Preparation Product Portfolio
6.2.5 Sanofi-Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Insulin Preparation Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Tonghua Dongbao
6.4.1 Tonghua Dongbao Corporation Information
6.4.2 Tonghua Dongbao Description and Business Overview
6.4.3 Tonghua Dongbao Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Tonghua Dongbao Insulin Preparation Product Portfolio
6.4.5 Tonghua Dongbao Recent Developments/Updates
6.5 Ganlee
6.5.1 Ganlee Corporation Information
6.5.2 Ganlee Description and Business Overview
6.5.3 Ganlee Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ganlee Insulin Preparation Product Portfolio
6.5.5 Ganlee Recent Developments/Updates
6.6 United Laboratory
6.6.1 United Laboratory Corporation Information
6.6.2 United Laboratory Description and Business Overview
6.6.3 United Laboratory Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 United Laboratory Insulin Preparation Product Portfolio
6.6.5 United Laboratory Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Insulin Preparation Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 Amphastar
6.8.1 Amphastar Corporation Information
6.8.2 Amphastar Description and Business Overview
6.8.3 Amphastar Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amphastar Insulin Preparation Product Portfolio
6.8.5 Amphastar Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wockhardt Insulin Preparation Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Julphar Diabetes
6.10.1 Julphar Diabetes Corporation Information
6.10.2 Julphar Diabetes Description and Business Overview
6.10.3 Julphar Diabetes Insulin Preparation Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Julphar Diabetes Insulin Preparation Product Portfolio
6.10.5 Julphar Diabetes Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Preparation Industry Chain Analysis
7.2 Insulin Preparation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Preparation Production Mode & Process
7.4 Insulin Preparation Sales and Marketing
7.4.1 Insulin Preparation Sales Channels
7.4.2 Insulin Preparation Distributors
7.5 Insulin Preparation Customers
8 Insulin Preparation Market Dynamics
8.1 Insulin Preparation Industry Trends
8.2 Insulin Preparation Market Drivers
8.3 Insulin Preparation Market Challenges
8.4 Insulin Preparation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Insulin Preparation Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Preparation Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Preparation Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Preparation Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Preparation Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Preparation Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Preparation Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Preparation Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Preparation, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Preparation, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Preparation, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Preparation, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Preparation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Preparation as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Preparation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Preparation Sales by Region (2019-2024) & (K Units)
Table 18. Global Insulin Preparation Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Preparation Sales by Region (2025-2030) & (K Units)
Table 20. Global Insulin Preparation Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Preparation Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Preparation Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Preparation Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Preparation Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Preparation Sales by Country (2019-2024) & (K Units)
Table 27. North America Insulin Preparation Sales by Country (2025-2030) & (K Units)
Table 28. North America Insulin Preparation Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Preparation Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Preparation Sales by Country (2019-2024) & (K Units)
Table 32. Europe Insulin Preparation Sales by Country (2025-2030) & (K Units)
Table 33. Europe Insulin Preparation Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Preparation Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Preparation Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Preparation Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Insulin Preparation Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Insulin Preparation Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Preparation Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Preparation Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Insulin Preparation Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Insulin Preparation Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Preparation Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insulin Preparation Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insulin Preparation Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Insulin Preparation Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Insulin Preparation Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Preparation Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Preparation Sales (K Units) by Type (2019-2024)
Table 51. Global Insulin Preparation Sales (K Units) by Type (2025-2030)
Table 52. Global Insulin Preparation Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Preparation Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Preparation Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Preparation Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Preparation Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Preparation Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Preparation Price (US$/Unit) by Type (2019-2024)
Table 59. Global Insulin Preparation Price (US$/Unit) by Type (2025-2030)
Table 60. Global Insulin Preparation Sales (K Units) by Application (2019-2024)
Table 61. Global Insulin Preparation Sales (K Units) by Application (2025-2030)
Table 62. Global Insulin Preparation Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Preparation Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Preparation Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Preparation Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Preparation Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Preparation Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Preparation Price (US$/Unit) by Application (2019-2024)
Table 69. Global Insulin Preparation Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Insulin Preparation Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi-Aventis Corporation Information
Table 76. Sanofi-Aventis Description and Business Overview
Table 77. Sanofi-Aventis Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi-Aventis Insulin Preparation Product
Table 79. Sanofi-Aventis Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Insulin Preparation Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Tonghua Dongbao Corporation Information
Table 86. Tonghua Dongbao Description and Business Overview
Table 87. Tonghua Dongbao Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Tonghua Dongbao Insulin Preparation Product
Table 89. Tonghua Dongbao Recent Developments/Updates
Table 90. Ganlee Corporation Information
Table 91. Ganlee Description and Business Overview
Table 92. Ganlee Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ganlee Insulin Preparation Product
Table 94. Ganlee Recent Developments/Updates
Table 95. United Laboratory Corporation Information
Table 96. United Laboratory Description and Business Overview
Table 97. United Laboratory Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. United Laboratory Insulin Preparation Product
Table 99. United Laboratory Recent Developments/Updates
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Biocon Insulin Preparation Product
Table 104. Biocon Recent Developments/Updates
Table 105. Amphastar Corporation Information
Table 106. Amphastar Description and Business Overview
Table 107. Amphastar Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Amphastar Insulin Preparation Product
Table 109. Amphastar Recent Developments/Updates
Table 110. Wockhardt Corporation Information
Table 111. Wockhardt Description and Business Overview
Table 112. Wockhardt Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Wockhardt Insulin Preparation Product
Table 114. Wockhardt Recent Developments/Updates
Table 115. Julphar Diabetes Corporation Information
Table 116. Julphar Diabetes Description and Business Overview
Table 117. Julphar Diabetes Insulin Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Julphar Diabetes Insulin Preparation Product
Table 119. Julphar Diabetes Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Insulin Preparation Distributors List
Table 123. Insulin Preparation Customers List
Table 124. Insulin Preparation Market Trends
Table 125. Insulin Preparation Market Drivers
Table 126. Insulin Preparation Market Challenges
Table 127. Insulin Preparation Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Preparation
Figure 2. Global Insulin Preparation Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Preparation Market Share by Type in 2023 & 2030
Figure 4. Fast-acting Product Picture
Figure 5. Intermediate-acting Product Picture
Figure 6. Long-acting Product Picture
Figure 7. Global Insulin Preparation Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Insulin Preparation Market Share by Application in 2023 & 2030
Figure 9. Hospital Pharmacy
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Insulin Preparation Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insulin Preparation Market Size (2019-2030) & (US$ Million)
Figure 14. Global Insulin Preparation Sales (2019-2030) & (K Units)
Figure 15. Global Insulin Preparation Average Price (US$/Unit) & (2019-2030)
Figure 16. Insulin Preparation Report Years Considered
Figure 17. Insulin Preparation Sales Share by Manufacturers in 2023
Figure 18. Global Insulin Preparation Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Insulin Preparation Players: Market Share by Revenue in 2023
Figure 20. Insulin Preparation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Insulin Preparation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Insulin Preparation Sales Market Share by Country (2019-2030)
Figure 23. North America Insulin Preparation Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Insulin Preparation Sales Market Share by Country (2019-2030)
Figure 27. Europe Insulin Preparation Revenue Market Share by Country (2019-2030)
Figure 28. Germany Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Insulin Preparation Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Insulin Preparation Revenue Market Share by Region (2019-2030)
Figure 35. China Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Insulin Preparation Sales Market Share by Country (2019-2030)
Figure 46. Latin America Insulin Preparation Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Insulin Preparation Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Insulin Preparation Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Insulin Preparation Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Insulin Preparation by Type (2019-2030)
Figure 56. Global Revenue Market Share of Insulin Preparation by Type (2019-2030)
Figure 57. Global Insulin Preparation Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Insulin Preparation by Application (2019-2030)
Figure 59. Global Revenue Market Share of Insulin Preparation by Application (2019-2030)
Figure 60. Global Insulin Preparation Price (US$/Unit) by Application (2019-2030)
Figure 61. Insulin Preparation Value Chain
Figure 62. Insulin Preparation Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
